Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paola Secchiero

Showing results (11-20 of 212) with videos related to

Pageof 22
Sort By:
Current Pharmaceutical Design|December 8, 2004
TNF-related apoptosis-inducing ligand (TRAIL): a potential candidate for combined treatment of hematological malignanciesPaola Secchiero, Mauro Vaccarezza, Arianna Gonelli, et al.
Leukemia & Lymphoma|September 13, 2006
TRAIL, caspases and maturation of normal and leukemic myeloid precursorsFederica Corallini, Daniela Milani, Vanessa Nicolin, et al.
Experimental Diabetes Research|August 9, 2011
Cell-based therapies for diabetic complicationsStella Bernardi, Giovanni Maria Severini, Giorgio Zauli, et al.
Experimental and Therapeutic Medicine|November 6, 2014
Levels of circulating TNF-related apoptosis-inducing ligand in celiac diseaseClaudio Celeghini, Tarcisio Not, Alessia Norcio, et al.
Cellular and Molecular Life Sciences : CMLS|February 25, 2016
Clinical perspectives of TRAIL: insights into central nervous system disordersVeronica Tisato, Arianna Gonelli, Rebecca Voltan, et al.
Current Pharmaceutical Design|June 26, 2012
Potential role of TRAIL in the management of autoimmune diabetes mellitusStella Bernardi, Alessia Norcio, Barbara Toffoli, et al.
Haematologica|November 5, 2002
Human herpesvirus 7 infection impairs the survival/differentiation of megakaryocytic cellsArianna Gonelli, Prisco Mirandola, Vittorio Grill, et al.
Current Pharmaceutical Design|August 12, 2008
The MDM2 inhibitor Nutlins as an innovative therapeutic tool for the treatment of haematological malignanciesPaola Secchiero, Maria Grazia di Iasio, Arianna Gonelli, et al.
Mediators of Inflammation|June 27, 2014
Association of serum tumor necrosis factor-related apoptosis inducing ligand with body fat distribution as assessed by dual X-rays absorptiometryCarlo Cervellati, Paola Secchiero, Gloria Bonaccorsi, et al.
Current Drug Targets|June 9, 2012
TRAIL as biomarker and potential therapeutic tool for cardiovascular diseasesStella Bernardi, Daniela Milani, Bruno Fabris, et al.
Pageof 22

Showing results (11-20 of 212) with videos related to

Sort By:
Pageof 22
Current Pharmaceutical Design|December 8, 2004
TNF-related apoptosis-inducing ligand (TRAIL): a potential candidate for combined treatment of hematological malignanciesPaola Secchiero, Mauro Vaccarezza, Arianna Gonelli, et al.
Leukemia & Lymphoma|September 13, 2006
TRAIL, caspases and maturation of normal and leukemic myeloid precursorsFederica Corallini, Daniela Milani, Vanessa Nicolin, et al.
Experimental Diabetes Research|August 9, 2011
Cell-based therapies for diabetic complicationsStella Bernardi, Giovanni Maria Severini, Giorgio Zauli, et al.
Experimental and Therapeutic Medicine|November 6, 2014
Levels of circulating TNF-related apoptosis-inducing ligand in celiac diseaseClaudio Celeghini, Tarcisio Not, Alessia Norcio, et al.
Cellular and Molecular Life Sciences : CMLS|February 25, 2016
Clinical perspectives of TRAIL: insights into central nervous system disordersVeronica Tisato, Arianna Gonelli, Rebecca Voltan, et al.
Current Pharmaceutical Design|June 26, 2012
Potential role of TRAIL in the management of autoimmune diabetes mellitusStella Bernardi, Alessia Norcio, Barbara Toffoli, et al.
Haematologica|November 5, 2002
Human herpesvirus 7 infection impairs the survival/differentiation of megakaryocytic cellsArianna Gonelli, Prisco Mirandola, Vittorio Grill, et al.
Current Pharmaceutical Design|August 12, 2008
The MDM2 inhibitor Nutlins as an innovative therapeutic tool for the treatment of haematological malignanciesPaola Secchiero, Maria Grazia di Iasio, Arianna Gonelli, et al.
Mediators of Inflammation|June 27, 2014
Association of serum tumor necrosis factor-related apoptosis inducing ligand with body fat distribution as assessed by dual X-rays absorptiometryCarlo Cervellati, Paola Secchiero, Gloria Bonaccorsi, et al.
Current Drug Targets|June 9, 2012
TRAIL as biomarker and potential therapeutic tool for cardiovascular diseasesStella Bernardi, Daniela Milani, Bruno Fabris, et al.
Pageof 22